Loyola Medicine Appoints Regional Vice President of Oncology

For Immediate Release

Contact: 
Tom VanNevel 
Public Relations Manager 
574-335-4566, office
574-404-1048, cell
Thomas.VanNevel@sjrmc.com

MAYWOOD, IL – Loyola Medicine has appointed William Small, Jr., MD, FACRO, FACR, FASTRO, as vice president of oncology for Trinity Health’s Illinois/Indiana region, effective immediately. 

In this role, Dr. Small will oversee oncology services across Trinity’s five regional hospitals. He will lead the development and integration of oncology services across multiple specialties, fostering seamless collaboration between medical, surgical and radiation oncology, as well as other related disciplines. He will also spearhead growth initiatives, elevate patient-centered quality care, and further strengthen Loyola Medicine's position as a regional leader in oncology services. 

Dr. Small will also play a pivotal role in expanding oncology care to the communities served by Saint Joseph Health System in Indiana. His leadership will be instrumental in building a comprehensive, integrated oncology program that brings high-quality, compassionate cancer care closer to home for our Indiana patients and their families.  

Dr. Small joined Loyola Medicine in 2013 as chair of the department of radiation oncology. In 2018, he was appointed as the director of the Cardinal Bernardin Cancer Center and has served in this dual role since that time. Under Dr. Small's leadership, the department of radiation oncology has become one of the leading programs in the country, offering cutting-edge treatments such as intraoperative radiation therapy (IORT), online adaptive MRI-guided radiation therapy, and our latest offering, low-dose radiation therapy for osteoarthritis. Loyola was the first academic medical center in the Chicago area to offer high-dose rate (HDR) prostate brachytherapy and draws patients from throughout the Midwest for this treatment. As director of the cancer center, he has led initiatives in research development, recruitment and community outreach with the goal of attaining designation as an NCI cancer center. 

With more than 30 years of experience in oncology leadership, research, and clinical practice, Dr. Small is an internationally recognized expert whose vision and dedication will be invaluable as Loyola continues to grow and evolve its oncology services. He has authored more than 330 scientific articles, 33 book chapters and 7 books, including one of the leading textbooks in radiation oncology. He has held innumerable leadership positions, including past chair of the Gynecological Cancer Intergroup, American College of Radiation Oncology board, and president-elect of the American Radium Society. He has been the international principal investigator on clinical trials that have changed the way we treat cancer and currently continues to serve in a leadership role for NRG Oncology.   

"We are thrilled to welcome Dr. Small to this important leadership role within our organization. His exceptional clinical expertise, research contributions and unwavering commitment to community health make him an ideal leader to advance the oncology care offered at Loyola Medicine and Saint Joseph Health System," said Shawn P. Vincent, president and CEO of Loyola Medicine. "I am confident that under his leadership, Loyola Medicine and Saint Joseph Health System will continue to advance the care we provide to our patients, colleagues, and the communities we are privileged to serve."